Longitude Capital
  • ABOUT
  • TEAM
  • PORTFOLIO
  • NEWS
  • CONTACT
  • LP LOGIN
Select Page

Jazz Pharmaceuticals Announces FDA Approval of Defitelio® (defibrotide sodium) for the Treatment of Hepatic Veno-Occlusive Disease (VOD) with Renal or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation (HSCT)

by longitudeadmin | Mar 30, 2016 | Portfolio News

Venus Concept Receives Clearance by U.S. Food and Drug Administration for Venus Versa™ for over 20 Common Clinical Indications

by longitudeadmin | Mar 24, 2016 | Portfolio News

Collegium Reports 2015 Financial Results and Provides Corporate Update

by longitudeadmin | Mar 15, 2016 | Portfolio News

Rapid Micro Biosystems Appoints Natale “Nat” Ricciardi to Board of Directors

by longitudeadmin | Mar 15, 2016 | Uncategorized

Aimmune Therapeutics Announces Phase 2 Follow-On Study of AR101 for the Treatment of Peanut Allergy Demonstrated Increased Desensitization and Improved Tolerability with Low-Dose Maintenance

by longitudeadmin | Mar 6, 2016 | Portfolio News

« Older Entries
Next Entries »

Media Contact

Maggie Jamison

mjamison@longitudecapital.com

650-854-5700

  • Facebook
  • Twitter
  • Google
  • RSS
footer-logo

LP Login

© 2026 Longitude Capital. All rights reserved.
  • Privacy Policy
  • Disclaimer